Mangalam Drugs & Organics (BOM:532637) Total Liabilities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Total Liabilities?

Mangalam Drugs & Organics's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0 Mil.

Mangalam Drugs & Organics's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹2,161.42 Mil) but then declined from Sep. 2024 (₹2,161.42 Mil) to Dec. 2024 (₹0.00 Mil).

Mangalam Drugs & Organics's annual Total Liabilities increased from Mar. 2022 (₹1,778.64 Mil) to Mar. 2023 (₹2,076.73 Mil) but then declined from Mar. 2023 (₹2,076.73 Mil) to Mar. 2024 (₹1,979.07 Mil).

Mangalam Drugs & Organics Total Liabilities Historical Data

The historical data trend for Mangalam Drugs & Organics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Total Liabilities Chart

Mangalam Drugs & Organics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

1,267.28

1,333.23

1,778.64

2,076.73

1,979.07

Mangalam Drugs & Organics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															-	1,979.07	-	2,161.42	-

Mangalam Drugs & Organics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mangalam Drugs & Organics's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1640.611	+	(184.879	+	153.58
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	1,979

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	3337	-	1357.93
	=	1,979

Mangalam Drugs & Organics's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	N/A	-	N/A
	=	N/A

Mangalam Drugs & Organics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Total Liabilities

Traded in Other Exchanges

MANGALAM:India

Address

P. D'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001

Website

https://www.mangalamdrugs.com

Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines